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Thrombin Generation and Inactivation in the Presence of Antithrombin 111 and 
Heparin 
The0 Lindhout,* Dominique Baruch, Pieter Schoen, Jo Franssen, and H. Coenraad Hemker 
Department of Biochemistry, Biomedical Center, University of Limburg, Maastricht, The Netherlands 
Received November 5 ,  1985; Revised Manuscript Received January 21, 1986 
ABSTRACT: W e  have determined the rate constants of inactivation of factor X, and thrombin by antithrombin 
"heparin during the process of prothrombin activation. The second-order rate constant of inhibition of 
factor X, alone by antithrombin 111 as determined by using the synthetic peptide substrate S-2337 was found 
to be 1.1 X lo6 M-' min-'. Factor X, in prothrombin activation mixtures that contained prothrombin, and 
either saturating amounts of factor V, or phospholipid (20 mol % dioleoylphosphatidylserine/80 mol % 
dioleoylphosphatidylcholine, 10 pM),  was inhibited by antithrombin I11 with a second-order rate constant 
that was essentially the same: 1.2 X lo6 M-I min-'. When both factor V, and phospholipid were present 
during prothrombin activation, factor X, inhibition by antithrombin 111 was reduced about 10-fold, with 
a second-order rate constant of 1.3 X lo5 M-' min-'. Factor X, in the prothrombin activation mixture that 
contained both factor V, and phospholipid was even more protected from inhibition by the antithrombin 
111-heparin complex. The first-order rate constants of these reactions a t  200 n M  antithrombin 111 and 
normalized to heparin at 1 pg/mL were 0.33 and 9.5 min-' in the presence and absence of factor V, and 
phospholipid, respectively. When the prothrombin concentration was varied widely around the K,,, for 
prothrombin, this had no effect on the first-order rate constants of inhibition. It is our conclusion that factor 
X, when acting in prothrombinase on prothrombin is profoundly protected from inhibition by antithrombin 
111 in the absence as  well as  in the presence of heparin. The second-order rate constant (4.5 X lo5 M-I 
min-') of inhibition of thrombin activity generated during prothrombin activation was found to be (1) constant 
during the time course of prothrombin activation, (2) independent of the composition of the prothrombin 
converting complex, and (3) about 4-fold lower than the second-order rate constant of inhibition of purified 
a-thrombin (1.9 X lo6 M-' m i d ) .  Surprisingly, heparin hardly enhanced the antithrombin 111 dependent 
rate of inhibition of thrombin activity formed during the initial phase of the prothrombin activation. The 
apparent pseudo-first-order rate constant of this reaction a t  200 n M  antithrombin 111 and normalized to 
heparin at  1 pg/mL was 0.10 min-I and independent of the stage of thrombin production. The rate constant 
of the purified a-thrombin/antithrombin 111 reaction, performed under the same conditions, was 25 min-' . 
This difference between the two reactions of thrombin inactivation is mainly caused by the fact that 
meizothrombin (des fragment l ) ,  rather than &-thrombin, is the major product during the initial phase of  
prothrombin activation. 
%e plasma protein antithrombin I11 is an inhibitor of serine 
proteases involved in the process of blood coagulation. Its 
action is dramatically enhanced by heparin. The main targets 
of antithrombin 111 are activated blood coagulation factor IX 
(factor IX,), factor X,, and thrombin [see Rosenberg (1982) 
and references cited therein]. 
The activation of prothrombin to thrombin is a mem- 
brane-mediated process requiring the binding of both factor 
X, and prothrombin to a negatively charged membrane surface 
(phospholipid vesicles). In addition, activated blood coagu- 
lation factor V (factor V,) that interacts with the membrane, 
factor X,, and prothrombin greatly increases the V,,, of 
prothrombin activation and lowers the K ,  for prothrombin 
when the membrane contains a low negative charge density 
[see van Rijn et al. (1984) and references cited therein]. 
Because in vivo both factor V, and phospholipids are present 
during factor X, catalyzed activation of prothrombin, a num- 
ber of studies were undertaken to reveal the effects of these 
so-called accessory components on factor X, inhibition by 
antithrombin 111. It has been shown that the inhibition of 
factor X, is reduced by phospholipids alone (Walker & Esmon, 
1979a; Ellis et al., 1984) and by phospholipids when factor 
V, is also present (Marciniak, 1973). 
* Correspondence should be addressed to this author. 
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Ellis et al. (1984) used the rate of prothrombin activation 
as a measure for residual factor X, activity. Quite unex- 
pectedly, the antithrombin 111 carried over in the prothrombin 
activation assay, as far as we understand, did not affect the 
thrombin activity nor factor X,. Walker and Esmon (1979b) 
reported that fragment 2 was found to slow down the rate of 
inhibition of a-thrombin about 3-fold. These observations 
provoke the investigation of the kinetics of the antithrombin 
I11 dependent neutralization of both factor X, and thrombin 
activity under more physiological conditions. Therefore, our 
purpose was to assess the kinetics of the antithrombin I11 
dependent inhibition of factor X, as part of the prothrombinase 
complex while acting on prothrombin as well as the kinetics 
of the antithrombin I11 dependent inhibition of thrombin ac- 
tivity as a product of the prothrombinase reaction. The basic 
assumption underlying the data analysis of the experiments 
presented here was that at any time during the prothrombin 
activation reaction in the presence of antithrombin 111, the 
observed rate of thrombin formation equals the actual rate of 
thrombin formation (proportional to the residual factor X, 
activity) minus the rate of inhibition of the thrombin activity. 
The same experiments were also performed in the presence 
of unfractionated heparin. 
Our results lead us to question the validity of a number of 
basic assumptions underlying the current ideas about the ef- 
0 1986 American Chemical Society 
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and complete inhibition of thrombin formation. After the 
addition of soybean trypsin inhibitor, 40-pL aliquots were 
removed at regular intervals and assayed for thrombin activity. 
Control experiments established that soybean trypsin inhibitor 
had no effect on the antithrombin III/thrombin reaction nor 
on the amidolytic activity of thrombin. 
Kinetic Analysis of Antithrombin IIIIFactor X ,  and An- 
tithrombin III/ Thrombin Reaction in Prothrombin Activation 
Mixtures. When thrombin is generated by prothrombinase- 
catalyzed activation of prothrombin in the presence of anti- 
thrombin 111, the appearance rate of amidolytic active 
thrombin,’ ur, will vary as a function of time, t ,  during pro- 
thrombin activation according to 
(1) 
where (u,), is the velocity of thrombin generation at time t and 
(q), is the velocity of the antithrombin III/thrombin reaction 
at time t .  In all experiments, the initial antithrombin I11 
concentration was significantly greater than the protease 
concentrations, so that the protease/antithrombin 111 reaction 
followed pseudo-first-order kinetics over the time course 
studied. Thus, when at any interval prothrombin activation 
is blocked, (uJt can be calculated by multiplying the observed 
pseudo-first-order rate constant of the antithrombin III/ 
thrombin reaction by the thrombin concentration. 
It is important to note that the antithrombin III/protease 
reaction is a two-step reaction. The reversible interaction 
between antithrombin I11 and thrombin (& = 1.4 X M 
in the absence of heparin) is followed by a conversion into a 
stable antithrombin III/thrombin complex, resulting in the 
inactivation of thrombin, k = 10.4 s-I (Olson & Shore, 1982). 
Thus, the reaction can be analyzed by pseudo-first-order ki- 
netics only when both the antithrombin I11 and protease 
concentrations are far below the Kd value. This condition holds 
for our heparin-free experiments. 
The pseudo-first-order rate constant of the antithrombin 
III/factor X, reaction can be obtained when (u,), is plotted 
exponentially vs. t .  The velocity of thrombin generation, u,, 
at time t was calculated from eq 1 .  The appearance rate of 
amidolytic active thrombin, ur, at time t was determined from 
the slope of the thrombin generation curve at time t .  
The same mathematical method was used for analysis of 
the data from the heparin-dependent reactions. Again, the 
pseudo-first-order approach will only work if the thrombin 
concentration remains far below its saturation value (Griffith, 
1983). Because the thrombin saturation values of the hepa- 
rin-dependent reaction, as reported in the literature, range from 
less than 2 nM (Pletcher & Nelsestuen, 1982) to 4 pM (Olson 
& Shore, 1982), we performed an independent determination 
of thrombin saturation under our own conditions. In separate 
experiments, prothrombin activation in the presence of heparin 
and antithrombin I11 was stopped at different time intervals 
by the addition of soybean trypsin inhibitor. Samples were 
taken and assayed for residual thrombin activity. Thus, the 
inhibition of thrombin could be studied at fixed antithrombin 
I11 and heparin concentrations but varying thrombin con- 
centrations. 
Electrophoretic Blotting Procedure. Proteins were subjected 
to slab gel electrophoresis in the presence of sodium dodecyl 
sulfate as described by Laemmli (1970). The proteins were 
then transferred to nitrocellulose sheets according to the 
procedure described by Towbin et al. (1979). The electro- 
(ur), = (ua), - (vi), 
fects of factor V, and phospholipid on the factor X,/anti- 
thrombin 111 reaction. Furthermore, a dramatic discrepancy 
was found between the kinetics of the heparin-dependent in- 
hibition of thrombin generated directly from prothrombin 
activation and the kinetics of heparin-dependent inhibition of 
a-thrombin by antithrombin 111. 
MATERIALS AND METHODS 
Materials. Phosphatidylcholine (dioleoyl), soybean trypsin 
inhibitor, and fatty acid free human serum albumin were 
purchased from Sigma. H-D-Phenylalanyl-L-pipecolyl-L-ar- 
ginine-p-nitroanilide dihydrochloride (S-2238) and benzoyl- 
L-isoleucyl-L-L-glutamyl( piperidy1)-L-glycyl-L-arginine-p- 
nitroanilide hydrochloride (S-2337) were obtained from Kabi 
AB, Sweden. Crude heparin (165 USP units/mg) was gen- 
erously provided by Pharmuka Laboratoires, France. All 
reagents used were of the highest grade commercially ob- 
tainable. 
Proteins. Bovine antithrombin I11 was prepared by the 
method of Thaler and Schmer (1975). All other bovine 
clotting factors were prepared and quantitated as previously 
described (Lindhout et al., 1982). 
Phospholipid Vesicle Preparation. 1,2-Dioleoyl-sn- 
glycero-3-phosphoserine (DOPS) was prepared from 1,2- 
dioloeyl-sn-glycero-3-phosphocholine (DOPC) as described by 
Comfurius and Zwaal (1977). Sonicated vesicle solutions were 
prepared from mixtures of DOPS (20 mol %) and DOPC (80 
mol %) in a buffer that contained 50 mM tris(hydroxy- 
methy1)aminomethane hydrochloride (Tris-HC1)/ 175 mM 
NaC1, pH 7.9, as described by de Kruijff et al. (1975). 
Determination of Inhibition Rate of Purified Proteases. 
The neutralization of factor X, and thrombin by antithrombin 
I11 was investigated under pseudo-first-order conditions. 
Factor X, or thrombin was incubated at 37 O C  in 50 mM 
Tris-HC1, 175 mM NaCl, and 0.5 mg of human serum al- 
bumin/mL, pH 7.9, with antithrombin 111. At timed intervals 
after the addition of the protease, 10-pL aliquots were removed 
into 590 pL of substrate solution [containing 50 mM Tris-HC1, 
175 mM NaCl, 20 mM ethylenediaminetetraacetic acid 
(EDTA), 0.5 mg of human serum albumin/mL, and 0.22 mM 
S-2238 or S-2337, pH 7.91 at 37 O C .  After 4 min, 300 pL 
of 50% acetic acid (v/v) was added, and the absorbance of 
the mixture was measured at 405 nm against a blank by using 
an Aminco DW-2 spectrophotometer. The rates of thrombin 
and factor X, inhibition by antithrombin 111 after sampling 
into the substrate solution were found to be sufficiently slow 
so as to not result in measurable enzyme inhibition. The 
residual enzyme activity was calculated from a standard curve 
constructed under the same conditions from known amounts 
of thrombin or factor X, and exponentially plotted vs. reaction 
time. 
Neutralization of Factor X ,  and Thrombin by Antithrombin 
I I I  in Prothrombin Activation Mixtures. Prothrombin was 
incubated with antithrombin 111 in the presence of either factor 
V,, phospholipid vesicles, or heparin or a combination of these 
in 50 mM Tris-HC1, 175 mM NaCl, 5 or 10 mM CaCl,, and 
0.5 mg of human serum albumin/mL, pH 7.9 at 37 O C ,  for 
4 min. Prothrombin activation was started by the addition 
of factor X,. The final concentrations of the reaction com- 
ponents are listed in Table I. At timed intervals after the 
addition of factor X,, 40-pL aliquots were removed into 560 
pL of the aforementioned solutions of S-2238. Thrombin 
concentrations were determined as described before. In sep- 
arate experiments, soybean trypsin inhibitor (20 pg/mL) was 
added to prothrombin activation mixtures a t  known intervals 
after the addition of factor X,, resulting in an instantaneous 
’ “Amidolytic active thrombin” or “thrombin activity” is used 
throughout this paper to indicate that this activity is not necessarily 
identical with the formation of a-thrombin. 
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Table I: Conditions of Prothrombin Activation’ 
prothrombin rate of comp of prothrombinase complex 
FXa FV, phospholipid Ca2+ concn thrombin formation 
(nM) (nM) (uM) (mM) (uM) (11. min-l X9-I) 
0.003 0.1 10 
1.5 20.0 
4.0 5 
5 1 .o 
5 6.0 
10 0.5 
2000 
2 
0.6 
“The reactions were performed in a buffer containing 0.05 M Tris/0.175 M NaC1/0.5 mg of human serum albumin/mL, pH 7.9 at 37 O C .  
Abbreviations: FX.. factor X,: FV,, factor V,. 
30 1 
25 
0 2 4 6 8 1 0 1 2  
REACTION TIME ( m i d  
FIGURE 1 :  Inhibition of thrombin formation and thrombin activity 
in prothrombin activation mixtures by antithrombin 111. Prothrombin 
(0.5 wM) was activated by factor X, (4.0 nM)/phospholipid ( 5  
pM/CaCI, (10 mMj either in the absence (0) or in the presence (A) 
of 100 nM antithrombin 111. At timed intervals, samples were taken 
and assayed for thrombin activity. In separate experiments, soybean 
trypsin inhibitor (20 fig/mLj was added 6 min after starting the 
reaction with factor X,. The time courses of thrombin activity are 
indicated by the dashed lines. 
phoretic blots were soaked in 0.1 % bovine serum albumin and 
0.05% Tween in phosphate-buffered saline. In essence, the 
immunological detection of antithrombin I11 and antithrombin 
III/protease complexes was performed as described by Towbin 
et al. (1979). The first antiserum was rabbit antihuman an- 
tithrombin I11 (Sigma). W e  used horseradish peroxidase 
conjugated swine anti-rabbit IgG (Dakopatts, Denmark) as 
an indicator. For the color reaction, the blots were soaked in 
a solution of 0.5 mg of diaminobenzidine tetrahydro- 
chloride/mL (Fluka) and 0.01% HzOz in 0.05 M Tris-HCI, 
pH 7.5. This solution was freshly prepared and filtered before 
use. 
RESULTS 
Activation of Prothrombin to Thrombin in the Presence of 
Antithrombin III .  The experimental conditions of prothrombin 
activation that were used to study the inhibitory action of 
antithrombin 111 are summarized in Table I. The reactions 
were initiated by the addition of factor X,. Under all con- 
ditions, the rate of thrombin formation was proportional to 
the factor X, concentration, and when performed in the ab- 
sence of antithrombin I11 linear during the time of the ex- 
periment. 
In the presence of antithrombin 111, the rate of appearance 
of thrombin activity decreased in time. We assumed that this 
was due to the inactivation of factor X, and the inhibition of 
thrombin activity. A typical curve is shown in Figure 1. 
To distinguish between the antithrombin I11 action on 
thrombin and that on factor X,, we inactivated factor X, by 
0 4 8 12 16 
time (min) 
FIGURE 2: Pseudo-first-order plots of inhibition of thrombin activity 
in prothrombin activation mixtures by antithrombin 111. Conditions 
of prothrombin activation in the presence of antithrombin 111 were 
as given in Figure 1. After the addition of soybean trypsin inhibitor, 
samples were taken and assayed for residual thrombin activity. The 
expressions are various time intervals of addition of soybean trypsin 
inhibitor: (0) 2 min; (0) 4 min; (A) 6 min; (A) 8 min; (0) 10 min. 
soybean trypsin inhibitor. Thus, by preventing further 
thrombin formation, the inhibition of thrombin activity can 
be studied separately. As shown in Figure 1, soybean trypsin 
inhibitor instantaneously and completely inhibited thrombin 
production, whereas it had no effect on thrombin activity 
(upper curve). When soybean trypsin inhibitor was added a t  
timed intervals after the start of prothrombin activation in the 
presence of antithrombin 111, the decrease in thrombin activity 
is solely due to the antithrombin III/thrombin reaction (lower 
curve). As shown in Figure 2, the reaction followed apparent 
first-order kinetics. We found that the pseudo-first-order rate 
constants of inhibition of thrombin activity ( k ’  = 0.04 min-l) 
did not vary with the stage of thrombin production. Knowing 
the rate constant of inhibition of thrombin activity, we can 
calculate the rate of inhibition of thrombin at any known 
concentration of thrombin, i.e., a t  any point of the curve of 
thrombin activity vs. time. From the same curve, the rate of 
appearance of thrombin activity can be determined from the 
slope a t  time t .  The sum of this rate and the rate of disap- 
pearance gives the actual rate of prothrombin activation a t  
any point of the thrombin generation curve. The latter then 
is a true measure for the residual factor X, activity a t  time 
t (Figure 3). From an exponentional plot of the rate of 
prothrombin activation (prothrombinase activity) vs. time, the 
pseudo-first-order rate constant of inhibition of factor X, by 
antithrombin 111 can be estimated (Figure 3, inset). 
Inhibition of Thrombin Activity in Prothrombin Activation 
Mixtures. Rate constants of inhibition of thrombin activity 
were determined after blocking prothrombin activation by 
soybean trypsin inhibitor (see Figures 1 and 2). The depen- 
dency of the pseudo-first-order rate constant of inhibition of 
thrombin activity on the antithrombin 111 concentration under 
different conditions of prothrombin activation is shown in 
Figure 4. The second-order-rate constants of inhibition are 
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Table 11: Second-Order Rate Constants of Inhibition of Factor X, 
and Thrombin bv Antithrombin 111 
second-order rate 
constant" (M-' min-') 
condition thrombin factor X, 
free proteases 19.0 x 105 11.0 x 105 
4.3 x 105 1.3 x 105 
4.4 x 105 11.0 x 105 
XaIPL 4.9 x 105 12.0 x 105 
a-thrombin plus added componentsb 
prothrombin activationC 
20.0 X los 
Xa/Va/PLd 
XaIVa 
The second-order rate constants were determined as described un- 
der Materials and Methods. bInhibition of a-thrombin in the presence 
of prothrombin activation reactants. CThe conditions of prothrombin 
activation were as listed in Table I. The rate constants are given for 
the inhibition of the thrombin activity formed during prothrombin ac- 
tivation and for factor X, as part of the prothrombinase complex. dPL, 
phospholipid. 
listed in Table 11. Under the different conditions of pro- 
thrombin activation, we measured identical rate constants of 
inhibition (4.5 X lo5 M-' min-' ). However, the rate constants 
were markedly reduced when compared with the inhibition 
It might be questioned whether the prothrombin activation 
reactants (e.g., factor V,, phospholipid, Ca2+, and pro- 
thrombin) caused the reduced rate of inhibition of thrombin 
activity. To  this end, pure a-thrombin (10 nM) was added 
to a mixture containing factor X, (3 pM), factor V, (0.1 nM), 
phospholipid (10 pM), Ca2+ ( 5  mM), prothrombin (1 pM), 
and soybean trypsin inhibitor (20 pg/mL). Because of the 
presence of soybean trypsin inhibitor, no thrombin formation 
occurred. After an incubation of 5 min at 37 OC, antithrombin 
I11 was added, and samples were taken a t  different time in- 
tervals to determine residual a-thrombin activity. The anti- 
thrombin 111 concentration varied between 50 and 300 nM. 
The second-order rate constant of inhibition of a-thrombin 
under these conditions was found to be 2.0 X lo6 M-I m i d ,  
indicating that the prothrombin activation components had 
no effect on the rate constant of inhibition (Table 11). 
Inhibition of Factor X, in Prothrombin Activation Mixtures. 
Following the aforementioned procedure (see Figure 3), in- 
of a-thrombin (1.9 X lo6 M-' min-' ). 
0  100 200 300 
ANTITHROMBIN 111 (nM) 
FIGURE 4: Pseudo-first-order rate constant of inhibition of thrombin 
activity as a function of antithrombin 111 concentration. Prothrombin 
was activated by (0 )  factor X,/factor V,/phospholipid/Ca2+, (0) 
factor X,/factor V,/Ca2+, and (A) factor X,/phospholipid/Ca2+. The 
concentrations of the reactants are listed in Table I, rows 1, 2 ,  and 
3, respectively. Antithrombin I11 was present at various concentrations. 
The pseudo-first-order rate constants of inhibition of thrombin activity 
were determined as described in Figure 2 .  The pseudo-first-order 
rate constant of inhibition of a-thrombin (B) was determined as 
described under Materials and Methods. 
0.401 ' 1  
0.321 
- 0.24- 
E 
'x 016 
E .- - - 
0.08 - 
a . 
0 100 200 300 
ANTITHROMBIN 111 ( n M )  
FIGURE 5 :  Pseudo-first-order rate constant of inhibition of factor X, 
as a function of antithrombin 111 concentration. Prothrombin was 
activated by (0) factor X,/factor V,/phospholipid/Ca2+, (0) factor 
X,/factor V,/Ca2+, and (A) factor X,/phospholipid/Ca2+. The 
concentrations of the various reaction components are listed in Table 
I, rows 1, 2, and 3, respectively. The pseudo-first-order rate constant 
of inhibition of factor X, was determined as described in Figure 3. 
The pseudo-first-order rate constants of inhibition of free factor X, 
(m) were determined as described under Materials and Methods. 
hibition of factor X, by antithrombin I11 was studied in pro- 
thrombin activation mixtures of different composition. In 
addition, the antithrombin 111 concentration was varied be- 
tween 50 and 300 nM in order to obtain the second-order rate 
constant of inhibition of factor X, under these conditions. 
The dependency of the pseudo-first-order rate constant of 
inhibition of factor X, under the different conditions of pro- 
thrombin activation on the antithrombin 111 concentration is 
shown in Figure 5.  The validity of our measuring system is 
indicated by the observed linear relationships. In addition, 
the first-order plots extrapolated to within 10% of the rate of 
thrombin formation in the absence of antithrombin I11 (Figure 
3, inset). The second-order rate constants are listed in Table 
11. When compared with the second-order rate constant of 
inhibition of factor X, alone, as assayed with the synthetic 
peptide substrate S-2337, it is clearly shown that the inhibition 
of factor X, is reduced only when both factor V, and phos- 
pholipid were present. No reduction of factor X, inhibition 
was found when prothrombin activation was performed in the 
presence of phospholipid and a t  a prothrombin concentration 
of 0.5 pM, Le., about 25-fold the K, value. It is apparent that 
under these conditions, prothrombin is not a competitive in- 
hibitor of the factor X,/antithrombin I11 reaction. Also, when 
factor V, and phospholipid were present, the second-order rate 
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FIGURE 6: Effect of heparin on thrombin generation in the presence 
of antithrombin 111. Prothrombin (1.0 pM) was activated by 3 pM 
factor X,, 0.1 nM factor V,, 10 pM phospholipid, and 5 mM CaZ+ 
in the absence (0 )  or presence of 200 nM antithrombin 111 and no 
heparin (A) or heparin at 100 (U), 200 (0), 300 (A), and 500 ng/mL 
(0). 
constant of inhibition of factor X, was found to be independent 
of the prothrombin concentration when varied between below 
and above the K ,  (data not shown). 
Heparin-Dependent Inhibition of Thrombin and Factor X ,  
during Prothrombin Activation. Prothrombin (1 pM) was 
activated by factor X, (3 pM), factor V, (0.1 nM), phos- 
pholipid (10 pM), and Ca2+ (5 mM) in the presence of 200 
nM antithrombin 111 and varying amounts of heparin (Figure 
6). The generation of thrombin activity decreased with in- 
creasing amounts of heparin as might be expected from a 
heparin concentration dependent stimulation of both the factor 
X,/antithrombin I11 and thrombin/antithrombin I11 reaction. 
The heparin-dependent inhibition of thrombin was assessed 
as described for the heparin-free system (see Figure 2). Thus, 
soybean trypsin inhibitor was added at different time intervals 
after the prothrombin activation was started in the presence 
of antithrombin 111 and heparin and the thrombin disap- 
pearance was measured during an additional 16-min period. 
Figure 7 shows the results of a typical experiment performed 
in the presence of 100 ng of heparin/mL. Each data point 
is the average (SD = 3%) of the residual thrombin activity 
as a percentage of the thrombin activity originally present at 
the time of addition of soybean trypsin inhibitor. As shown 
in the inset (Figure 7), the reaction followed pseudo-first-order 
kinetics, and the apparent pseudo-first-order rate constant of 
inhibition of thrombin was independent of the initial thrombin 
concentration when varied between 5.2 and 22 nM. Thus, the 
stage of thrombin production in the presence of heparin had 
no effect on the k'values at the time when the latter assay 
was made. It is our conclusion that under our conditions the 
pseudo-first order approach is useful and valid for the hepa- 
rin-containing reaction system. 
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FIGURE 8: Pseudo-first-order rate constant of inhibition of thrombin 
and factor X, activity by antithrombin 111 (200 nM) as a function 
of heparin concentration. (A) Inhibition of the prothrombinase activity 
(0) and of formed thrombin (0).  The reaction conditions were as 
given in Figure 6. (B) Inhibition of 12 nM factor X, (O), 5 nM 
a-thrombin (O), and 22 nM a-thrombin (*) in the absence of added 
prothrombinase components and prothrombin. Inhibition of 12 nM 
factor X, (A), 5 nM a-thrombin (A), and 22 nM a-thrombin (B) in 
the presence of 1 pM prothrombin, 5 mM Ca2+, 10 pM phospholipid, 
and 0.1 nM factor V,. The pseudo-first-order rate constants were 
determined as described under Materials and Methods. 
Figure 8A depicts the apparent pseudo-first-order rate 
constant of the inhibition of thrombin, which is directly formed 
by the prothrombinase complex, as a function of the heparin 
concentration. Surprisingly, under these conditions the 
thrombin/antithrombin I11 reaction is hardly stimulated by 
heparin. The rate constant when normalized to heparin at 1 
pg/mL was 0.1 min-I. 
One explanation that might account for the absence of a 
heparin effect is that some of the prothrombin activation 
components remove heparin from the thrombin/antithrombin 
I11 reaction. Therefore, we have determined the pseudo- 
first-order rate constant of inhibition of purified a-thrombin 
(5 and 22 nM) in a mixture containing 1.0 pM prothrombin, 
0.1 nM factor V,, 10 pM phospholipid, 5 mM Ca*+, and 
varying amounts of heparin. Under all conditions the reac- 
tions, followed for at least 80%, showed pseudo-first-order 
kinetics. Figure 8B shows that the prothrombinase components 
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and prothrombin reduced the heparin-stimulating effect about 
7-fold. When normalized to heparin a t  I sg/mL, the rate 
constants were 180 and 25 min-' in the absence or presence 
of added prothrombin and prothrombinase components, re- 
spectively. It appeared that prothrombin made the major 
contribution to this phenomenon. However, a 250-fold dif- 
ference was observed between the stimulating effect of heparin 
on the a-thrombin/antithrombin 111 reaction in the presence 
of added components and the prothrombinase-formed throm- 
bin/antithrombin 111 reaction. As shown later, this discrep 
ancy is explained by the formation of meizothrombin, rather 
than a-thrombin, as the major product of prothrombin acti- 
vation under our conditions. 
Because we found that in the heparin-containing reaction 
the apparent first-order rate constant of inhibition of thrombin 
was independent of the thrombin concentration, as already 
demonstrated for the heparin-free reaction, the same mathe- 
matical method was performed for the analysis of the hepa- 
rin-dependent antithrombin IlI/factor X, reactions during 
prothrombin activation. When the heparin concentration was 
varied between 50 and 500 ng/mL a t  a fixed antithrombin 
111 concentration (200 nM), the apparent pseudo-first-order 
rate constant of inhibition of prothrombinase activity increased 
linearly with the heparin concentration (Figure SA). Under 
the same conditions, we determined the apparent pseudo- 
first-order rate constant of inhibition of free factor X. (Figure 
8B). It appears that factor X, in the prothrombinase complex 
is greatly protected from inhibition by the heparindependent 
reaction. The pseudo-first-order rate constant, normalized to 
heparin at 1 rg/mL. was 0.33 m i d ,  whereas the normalized 
rate constant for the free factor XJantithrombin 111 reaction, 
either in the absence or in the presence of I pM prothrombin, 
was 9.5 min-I. 
Identification of the Molecular Species with Thrombin 
Acriuiry during Prorhrombin Activation. It has been reported 
that prothrombin fragment 2 reduced the rate of inhibition 
of thrombin by antithrombin 111 about 3-fold. The second- 
order rate constants for antithrombin 111 mediated inhibition 
of thrombin in the presence of saturating amounts of fragment 
2 and antithrombin 111 mediated inhibition of meizothrombin 
(des fragment I )  appeared to be identical (Walker & Esmon, 
1979b). Therefore, our results showing a reduced rate of 
inhibition of thrombin activity could be explained by the 
presence of prothrombin activation products fragment 1.2 
and/or fragment 2. Another interesting possibility might be 
the formation of meizothrombin as an intermediate in pro- 
thrombin activation (Rosing et al., 1986). In order to establish 
the presence of different molecular species with thrombin 
activity a t  nanomolar concentrations, we used the following 
procedure. At timed intervals, samples were removed from 
prothrombin activation mixtures containing prothrombin ( I  .O 
aM), factor X. (3 pM), factor V, (0.1 nM), and phospholipid 
(IO pM). The samples were incubated with antithrombin 111 
( I  r M )  and heparin ( I  pg/mL) a t  37 "C for IO min, Le., 
sufficiently to obtain complete inhibition of thrombin activity. 
Subsequently. the samples were analyzed by polyacrylamide 
gel electrophoresis in the presence of sodium dodecyl sulfate 
followed by a blotting procedure and detection of antithrombin 
111 by antibodies conjugated with peroxidase as described 
under Materials and Methods. The results are shown in Figure 
9. In addition lo a heavily stained band, comigrating with 
the large excess of free antithrombin 111, two antithrombin 
111 containing complexes are visualized: a major band co- 
migrating with the meizothrombin (des fragment I)/anti- 
thrombin 111 complex (M, I l0000) and a minor band co- 
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FIGURE 9 Identification of molecular s p i s  with thrombin activity 
in the prothrombin activation mixture. Prothrombin (1.0 pM) was 
activated by 3 pM factor XJO.1 nM factor VJIO pM phospholipid/S 
mM CaCI2. Samples were removed at the times indicated, incubated 
with antithrombin 111 ( I  pM) and heparin ( I  pg/rnL). and subjected 
to sodium dodecyl sulfate gel electrophoresis. (A) Unreduced samples; 
(E) disulfide-reduced sample. Abbreviations: ATIII, antithrombin 
111; MDFI. meirothrombin (des fragment I ) ;  T. a-thrombin; B. B 
chain of a-thrombin. Experimental details are given under Materials 
and Methods. 
migrating with a-thrombin/antithrombin 111 complex (M, 
91 000). Upon reduction, the two antithrombin 111 containing 
complexes were found at a position that corresponds to that 
of the thrombin B-chain/antithrombin 111 complex (M, 
75000). Weconclude that the major product of prothrombin 
activation under initial rate conditions was meizothrombin (des 
fragment I ) .  
DISCUSSION 
In the present paper, we report the results of a study on the 
inhibition of factor X. and thrombin by antithrombin I l l /  
heparin. Whereas other studies have used a synthetic peptide 
substrate or prothrombin to measure residual factor X, activity, 
our approach was to study factor X. inactivation under its 
actual working conditions, i.e., during prothrombin activation. 
An interesting advantage of this approach is that the effects 
of the reaction constituents like factor V,. phospholipid, and 
prothrombin (activation products) can be studied simultane- 
ously on both the inactivation of factor X. and the inhibition 
of thrombin activity. 
Inhibirion of Factor X,. Our experiments show that when 
prothrombin activation occurs at a phospholipid surface in the 
absence of factor V,, factor X. is not protected from inacti- 
vation by antithrombin 111. Under this condition. the sec- 
ond-order rate constant of inhibition of factor X, was found 
to be 1.2 X IO' M-I min-' which is identical with the rate 
constant of inhibition of factor X, alone as measured with a 
synthetic peptide substrate (Table 11). Because in the absence 
of phospholipid factor V, did not protect factor X. from in- 
activation either, it is evident that protection must arise from 
the formation of the phospholipid-bound factor XJfactor V, 
complex. 
Ellis et al. (1984) concluded that 'the protective effect is 
probably due to the factor V, that altered the binding of factor 
X. on the phospholipid surface in such a way that the steric 
hindrance to antithrombin 111 binding is increased. with the 
large bulk of the factor V, molecule perhaps contributing to 
this effect". Walker and Esmon (1979a) came to the same 
conclusion. Ellis et al. (1984) reasoned that since their assay 
only determined phospholipid-bound factor X, and not free 
factor X., they have determined the kinetics of inhibition of 
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during the initial phase of prothrombin activation. There has 
been a report on the effect of prothrombin fragment 2 on the 
inhibition of a-thrombin by antithrombin I11 (Walker & 
Esmon, 1979b). In addition, recent work from our laboratory 
has indicated that during the initial phase of prothrombin 
activation by factor X, prothrombin is mainly cleaved between 
Arg,,, and 11e324, resulting in amidolytic-active meizothrombin 
(Rosing et al., 1986). We found that the second-order rate 
constant of inhibition of a-thrombin by antithrombin I11 was 
about 4 times the rate constant of thrombin activity in the 
prothrombin activation mixtures and independent of the 
composition of the prothrombinase complex. Walker and 
Esmon (1979b) reported that fragment 2 was found to slow 
down the rate of inhibition of a-thrombin about 3-fold. 
Therefore, the presence of fragment 2 and/or fragment 1.2 
in our activation mixtures might be a plausible explanation 
for our findings. An alternative explanation is the formation 
of meizothrombin, because covalently and noncovalently 
linking of fragment 2 to thrombin gave the same second-order 
rate constants of inhibition (Walker & Esmon, 1979b). 
Therefore, we analyzed our activation mixtures for the pres- 
ence of meizothrombin. As shown, a considerable amount of 
meizothrombin (des fragment 1) was detected (Figure 9). 
Because meizothrombin appeared to be the main product 
under the conditions used, it can be questioned whether pure 
a-thrombin can be used as a standard to measure the reaction 
product of prothrombin activation. However, on the basis of 
functional molar concentrations as assessed by active-site ti- 
tration of meizothrombin preparations obtained by the acti- 
vation of prothrombin by Echis carinatus venom and a- 
thrombin preparations, we found no differences between the 
reactivity of a-thrombin and meizothrombin toward the syn- 
thetic peptide substrate S-2238. 
Intriguing is the observation that when heparin is studied 
in prothrombin activation mixtures, it had hardly any effect 
on the inhibition of thrombin activity by antithrombin 111. We 
ruled out that this phenomenon was solely caused by the he- 
parin binding properties of prothrombin. As yet, it remains 
to be established to what extent and in which mode fragment 
2 and/or fragment 1.2 either covalently or noncovalently bound 
to a-thrombin affects the interaction between heparin and 
thrombin. Recently, we initiated a study on the interaction 
between meizothrombin and heparin. Our preliminary results 
indicate that in contrast to a-thrombin, meizothrombin is 
unable to bind heparin. 
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ABSTRACT: The self-association equilibrium of spectrin has been studied by separating the molecular species 
present in the cooled reaction mixture by gel electrophoresis. The association constant for formation of 
the hexamer from dimer and tetramer is lower by an order of magnitude than that for the association of 
two dimers. The  association constant for the formation of the octamer from the hexamer is appreciably 
larger, and the value appears to reach a constant level for higher oligomers. These observations are explained 
in terms of conformational strain due to formation of cyclic structures, the distortion being greatest on passing 
from the tetramer to the hexamer. The association for a single-site interaction between the dimer and a 
univalent fragment has also been analyzed. The results show that the free energy generated by a single-point 
interaction is much greater than that obtained by averaging over all pairwise interactions within the oligomers, 
correcting for the effect of cratic entropy. The  results are related to the association state of the spectrin 
prevailing in the cell. Phosphorylation a t  the physiological sites in the dimer does not appreciably change 
the thermodynamics of self-association, at  least up to the hexamer. 
s p e c t r i n ,  the major protein of the membrane cytoskeleton 
in red cells, is constructed of heterodimers. The two chains, 
a and p, are resolved in gel electrophoresis in the presence of 
sodium dodecyl sulfate (SDS)' into a doublet with molecular 
weights of about 250000 and 230000. The two components 
differ in sequence but show extensive homologies, both being 
made up of not fully identical repeating units (Speicher & 
Marchesi, 1984). The dimer is an elongated, somewhat flexible 
structure, with a length in the electron microscope of 100 nm 
(Shotton et al., 1979). The dimers will undergo self-association 
in a head-to-head manner (Ungewickell & Gratzer, 1978) to 
give a tetramer 200-nm long (Shotton et al., 1979). The 
tetramer is the form predominantly present in the cell, and 
its interconversion with the dimer is characterized by a high 
Abbreviations: SDS, sodium dodecyl sulfate; HEPES, N-(2- 
hydroxyethyl)piperazine-N'-2-ethanesulfonic acid: EDTA, ethylenedi- 
aminetetraacetic acid; Tris, tris(hydroxymethy1)aminomethane: Bicine, 
N,N-bis(2-hydroxyethyl)glycine. 
activation energy (Ungewickell & Gratzer, 1978). Thus the 
reaction proceeds on a time scale of minutes to hours at a 
temperature of 30 OC or more, whereas below about 20 "C 
there is no measurable change over a period of many days. 
Later work showed that, at sufficiently high spectrin con- 
centrations, higher oligomeric forms than the tetramer are 
generated (Morrow & Marchesi, 1981; Morrow et al., 1981) 
and indeed occur in the cell (Tyler et al., 1980; Morrow & 
Marchesi, 1981; Nermut, 1981; Liu et al., 1984). It could be 
inferred, and electron microscopy showed (Tyler et al., 1980; 
Liu et al., 1984), that the higher oligomers are formed not by 
end-to-end association, but by branching; that is to say, each 
constituent dimer is bound at the end that carries the asso- 
ciation sites to two separate dimer partners. This is in 
structural terms an unusual situation, for it implies that the 
chains can deform without a prohibitive cost in strain energy 
to allow a correct apposition of binding sites. The thermo- 
dynamic characteristics of this system are analzyed here and 
must be supposed to relate to the function of spectrin in the 
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